Skip to main content
Equibles

Assenagon Asset Management S.A.

Position in PCRX — Pacira BioSciences, Inc.

CIK 1546007 SENNINGERBERG, N4
Back to PCRX Full portfolio

Position in PCRX

as of Jun 30, 2026 · filed Aug 21, 2026
Position Value
$2,573,253
-$8,688,247 QoQ
Shares Held
101,429
-76.7% QoQ
Ownership
0.254%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#57
of 254 holders
Holding Since
Jun 2020
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PCRX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Assenagon Asset Management S.A. holds $514,912,865 across 20 Drug Manufacturers - Specialty & Generic names. PCRX ranks #14 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TEVA
Teva Pharmaceutical Industries Ltd
 3,056,017 $103,537,855
2 LNTH
Lantheus Holdings, Inc.
 714,980 $79,319,881
3 VTRS
Viatris Inc
 4,989,006 $79,225,415
4 INDV
Indivior Pharmaceuticals, Inc.
 1,540,928 $63,224,275
5 UTHR
UNITED THERAPEUTICS Corp
 84,538 $45,805,224
6 AMRX
Amneal Pharmaceuticals, Inc.
 2,445,549 $42,332,453
7 NBIX
Neurocrine Biosciences Inc
 222,606 $37,518,015
8 ZTS
Zoetis Inc.
 389,335 $27,977,613

All Filings in PCRX

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,573,253 101,429
2025-12-31 $11,261,500 435,143
2025-09-30 $5,988,174 232,370
2025-06-30 $11,542,839 482,964
2025-03-31 $16,731,231 673,289
2024-12-31 $8,517,432 452,093
2024-09-30 $8,324,365 553,114
2024-06-30 $3,818,233 133,458
2024-03-31 $5,735,739 196,295
2023-12-31 $8,320,992 246,621
2023-09-30 $2,652,960 86,472
2023-06-30 $8,330,032 207,887
2023-03-31 $6,195,937 151,824
2021-12-31 $8,451,959 140,468
2021-09-30 $1,769,320 31,595
2021-06-30 $4,172,720 68,766
2021-03-31 $4,819,808 68,766
2020-12-31 $4,115,256 68,771
2020-06-30 $3,840,908 73,202